Efficacy of visual laser ablation of the prostate (VLAP) in patients with BPH

Abstract

From November 1992 to the present, 50 patients, most of whom suffering from severe cardiovascular, respiratory, neurological or hemocoagulative disorders, underwent laser prostatic ablation (VLAP) with Nd:YAG laser. Clinical and uroflowmetric follow-up at 6 weeks, 3 and 6 months showed significant improvement with low morbidity. We believe that VLAP is an alternative to TURP in patients with BPH. A better definition of techniques and overcoming the restrictions due to the learning curve could lead to even better results in the future.